HUNTINGTON NATIONAL BANK - VIROPHARMA INC ownership

Quarter-by-quarter ownership
HUNTINGTON NATIONAL BANK ownership history of VIROPHARMA INC
ValueSharesWeighting
Q3 2023$500.0%10.0%0.00%
Q2 2023$500.0%10.0%0.00%
Q1 2023$500.0%10.0%0.00%
Q4 2022$5010.0%0.00%
Q3 2022$010.0%0.00%
Q2 2022$010.0%0.00%
Q1 2022$010.0%0.00%
Q4 2021$010.0%0.00%
Q3 2021$010.0%0.00%
Q2 2021$010.0%0.00%
Q1 2021$010.0%0.00%
Q4 2020$010.0%0.00%
Q3 2020$010.0%0.00%
Q2 2020$010.0%0.00%
Q1 2020$010.0%0.00%
Q4 2019$010.0%0.00%
Q3 2019$010.0%0.00%
Q2 2019$010.0%0.00%
Q4 2018$010.0%0.00%
Q3 2018$0
-100.0%
1
-99.8%
0.00%
Q1 2011$11,000
+22.2%
5300.0%0.00%
Q4 2010$9,000
+12.5%
5300.0%0.00%
Q3 2010$8,000
+33.3%
530
-7.5%
0.00%
Q2 2010$6,000
-81.2%
573
-75.4%
0.00%
-100.0%
Q1 2010$32,000
+68.4%
2,3300.0%0.00%0.0%
Q4 2009$19,000
-13.6%
2,3300.0%0.00%0.0%
Q3 2009$22,000
+57.1%
2,3300.0%0.00%0.0%
Q2 2009$14,000
+16.7%
2,3300.0%0.00%0.0%
Q1 2009$12,0002,3300.00%
Other shareholders
VIROPHARMA INC shareholders Q1 2019
NameSharesValueWeighting ↓
GABELLI & Co INVESTMENT ADVISERS, INC. 479,941$23,925,0008.64%
WATER ISLAND CAPITAL LLC 2,477,454$123,501,0006.86%
Pentwater Capital Management LP 2,835,000$141,325,0004.07%
OXFORD ASSET MANAGEMENT LLP 3,059,478$152,515,0003.83%
LONGFELLOW INVESTMENT MANAGEMENT CO LLC 398,350$19,858,0003.26%
Twin Securities, Inc. 297,908$14,851,0003.22%
SHIKIAR ASSET MANAGEMENT INC 122,500$6,107,0002.65%
HARVEST MANAGEMENT LLC 36,000$1,795,0002.65%
HBK INVESTMENTS L P 2,691,527$134,173,0002.58%
PRICE MICHAEL F 400,000$19,940,0002.58%
View complete list of VIROPHARMA INC shareholders